Board appointment at Watson Pharmaceuticals
This article was originally published in Scrip
Watson Pharmaceuticals (US) has elected Christopher Bodine to its board of directors. The appointment brings the total number of board members to 10. Mr Bodine retired from CVS Caremark in January after 24 years with the company.
You may also be interested in...
Flagship Pioneering raised $1.1bn to fund life science companies emerging from Flagship Labs. ARCH, another frequent start-up co-founder, raised two funds totaling $1.46bn to back early-stage biotech.
LifeSignals plans to soon launch a biosensor patch to consumers to help them monitor for potential symptoms of COVID-19.
FDA and FTC's latest warning letters include the first firm marketing CBD products linked with bogus COVID-19 claims. Latest warnings also mark the first the agencies submitted based completely or nearly entirely on regulatory violations found in businesses social media postings.